Didier Demesmin, MD
Interventional Pain Medicine · Somerset, NJNPI 1336170216
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $20,000 of the $32,892 with a category attached, or 60.8%. Milestone Scientific Inc. accounts for 60.8% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2023 at $17,197 and has fallen 88.3% since, to $2,017 in 2025. Among interventional pain medicine clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 198 payments — averaging $166.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Milestone Scientific Inc.$20K
- Boston Scientific$4K
- Painteq LLC$3K
- Medtronic$1K
- Nevro Corp.$858
- Abbott$724
- plus $4K from 25 others
Across 14 payments — averaging $1991.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$9K
- AbbVie$9K
- Boston Scientific$8K
- Vertiflex, Inc.$2K
What the payments were for
- Consulting fees$20,00061%
- Travel & lodging$6312%
- Food & beverage$12,24737%
- Entertainment$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Milestone Scientific Inc. | 5 | $20,000 |
| Boston Scientific | 65 | $3,938 |
| Painteq LLC | 22 | $2,636 |
| Medtronic(2 entities) | 17 | $1,116 |
| Nevro Corp. | 11 | $858 |
| Abbott | 15 | $724 |
| Biotronik NRO, Inc. | 10 | $603 |
| Saluda Medical Americas, Inc. | 6 | $452 |
| Vertos Medical, Inc. | 7 | $435 |
| SPR Therapeutics, Inc | 4 | $337 |
| Globus Medical | 4 | $250 |
| Scilex Pharmaceuticals Inc. | 1 | $216 |
| Si-bone, Inc. | 3 | $207 |
| Stimwave Technologies Incorporated | 1 | $200 |
| Foundation Fusion Solutions, LLC | 5 | $160 |
| ETS Wound Care LLC | 1 | $135 |
| Nalu Medical, Inc. | 1 | $126 |
| Captiva Spine Inc | 1 | $94 |
| Bioventus LLC | 3 | $71 |
| Electronic Waveform Lab, Inc. | 2 | $57 |
| Pacira Therapeutics, Inc. | 4 | $56 |
| Pacira Pharmaceuticals Incorporated | 1 | $52 |
| Relievant Medsystems, Inc. | 1 | $33 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Avanos Medical | 1 | $23 |
| International Rehabilitative Sciences, Inc | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Integrity Implants Inc. | 1 | $13 |
| Redhill Biopharma Inc. | 1 | $13 |
| Vertiflex, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COMPUFLO EPIDURAL$20,000
- PAINTEQ$2,238
- GENERAL PAIN MANAGEMENT$707
- Omnia$467
- VenaSeal$452
- Prospera$447
- Evoke$337
- Senza$332
- SPRINT PNS System$296
- mild Device Kit$277
- ZTLido$216
- ETERNA$149
- INTELLIS ADAPTIVESTIM$147
- Proclaim Family of SCS IPGs$147
- WAVEWRITER ALPHA$138
- WaveWriter Alpha Prime 16$136
- MIRRAGEN ADVANCED WOUND MATRIX$135
- Nalu Neurostimulation System$126
- MYSTIM$117
- Superion Indirect Decompression System$117
How this compares
$32,892 in reported general payments places this provider in the 90th percentile of 82 interventional pain medicine providers in New Jersey.
See all interventional pain medicine providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 12 | $885 |
| Meloxicam | 14 | $25 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Somerset
- Brendan O'DonovanSomerset$4K
- Sachin ShahSomerset$4K
- Catvan leSomerset$3K
- Youssef JosephsonWest Deptford$496K
- Ali ValimahomedHolmdel$415K
- Saurabh DangEdgewater$157K
- Gabriele JasperBrick$114K
- Matthew LippChatham$67K
- Steve AydinFranklin Lakes$22K
- Kieran SlevinHainesport$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.